Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

OMA 2026 9 - 12 April 2026

Oral Semaglutide vs Orforglipron in Obesity – An Indirect Comparison

Authors :

Wojciech Michalak¹; Christian Laugesen ²; Naveen Rathor²; Phoebe Cowley ³; Rohan Chowdhury ³; Martin Bøg²

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Obesity

Congress poster

GLP-1 RA

Semaglutide (oral)

RWE HEOR